Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2011

01.05.2011 | Gynecologic Oncology

The use of MRI for selecting patients with endometrial cancer and significant co-morbidities for vaginal hysterectomy

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

The objective of this study is to ascertain the presence of extrauterine spread in radiologically early stage and grade endometrial cancer. This could be the basis for offering vaginal hysterectomy without salpingo-oophorectomy as an alternative option to primary radical radiotherapy in women with significant medical co-morbidities in whom laparotomy will be contraindicated.

Materials and methods

A retrospective cohort study assessing patients with clinically early stage endometrioid adenocarcinoma of the endometrium, treated at the Gynaecological Oncology Centre, Norfolk and Norwich University Hospital and James Paget University Hospital between January 2003 and July 2008. The cancer registry was reviewed, and 542 endometrial cancer cases were identified during the study period, of these 439 were endometrioid type. MR is the standard staging investigation unless there are contraindications. Demographic, clinic-pathologic and surveillance data were collected from hospital records, operative notes and histopathology reports. The histology included tumour type, stage and grade. Post-operative histopathological findings served as a reference standard. Sensitivity and specificity of pre-operative MRI scan were assessed.

Results

Of the 439 cases treated during the study periods, 415 patients had an MRI pre-operatively imaging and 14% of these cases showed signs of extrauterine spread. MRI staging was then compared with the histopathology staging; the latter was taken as the gold standard. In 8% of the cases where no spread was seen on MRI, the disease was actually spread outside uterine corpus mainly to the cervix and pelvic lymph nodes. The sensitivity, specificity, positive predictive value and negative predictive value for MRI were 56, 93, 60, and 92, respectively, while predicting early stage disease. There were three cases of adnexal metastases, where the tumour had already spread to uterine serosa. Two cases had poorly differentiated and one had moderately differentiated tumour.

Conclusions

The risk of adnexal metastasis is less than 1% in clinically early stage disease and highly unlikely if MRI suggests that the disease is confined to the inner half of the myometrium and low-grade disease. MRI has a high specificity and negative predictive value in endometrial cancer staging with reduced sensitivity of detecting cervical, adnexal and lymphatic spread. We suggest that vaginal hysterectomy might be a safe alternative to laparotomy in the treatment of radiological early stage disease in medically compromised elderly patients. The possibility of converting a vaginal approach to an abdominal route should be always taken into consideration.
Literatur
1.
Zurück zum Zitat Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36PubMedCrossRef Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. CA Cancer J Clin 51:15–36PubMedCrossRef
2.
Zurück zum Zitat ACOG practice bulletin, management of endometrial cancer. Obstet Gynecol 2005; 106:413 ACOG practice bulletin, management of endometrial cancer. Obstet Gynecol 2005; 106:413
3.
Zurück zum Zitat Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11(12):1531–1543PubMed Kaaks R, Lukanova A, Kurzer MS (2002) Obesity, endogenous hormones and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 11(12):1531–1543PubMed
4.
Zurück zum Zitat Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, endometrium. Int J Gynaecol Obstet 105:103PubMedCrossRef Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, endometrium. Int J Gynaecol Obstet 105:103PubMedCrossRef
5.
Zurück zum Zitat McCracken G, Hunter D, Morgan D, Price JH (2006) Comparison of laparoscopic-assisted vaginal hysterectomy, total abdominal hysterectomy and vaginal hysterectomy. Ulster Med J 75(1):54–58PubMed McCracken G, Hunter D, Morgan D, Price JH (2006) Comparison of laparoscopic-assisted vaginal hysterectomy, total abdominal hysterectomy and vaginal hysterectomy. Ulster Med J 75(1):54–58PubMed
6.
Zurück zum Zitat Gemer O, Bergman M, Segal S (2004) Ovarian metastasis in women with clinical stage I endometrial carcinoma. Acta Obstet Gynecol Scand 83(2):208–210PubMed Gemer O, Bergman M, Segal S (2004) Ovarian metastasis in women with clinical stage I endometrial carcinoma. Acta Obstet Gynecol Scand 83(2):208–210PubMed
7.
Zurück zum Zitat Lee TS, Jung JY, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2007) Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol 104(1):52–57PubMedCrossRef Lee TS, Jung JY, Kim JW, Park NH, Song YS, Kang SB, Lee HP (2007) Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol 104(1):52–57PubMedCrossRef
8.
Zurück zum Zitat Hoskins WJ, Perez CA, Young RC. Principles and practice of gynecologic oncology. 3rd edn. Lippincott, Philadelphia Hoskins WJ, Perez CA, Young RC. Principles and practice of gynecologic oncology. 3rd edn. Lippincott, Philadelphia
9.
Zurück zum Zitat Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. Cancer 60:2035–2041PubMedCrossRef Creasman WT, Morrow CP, Bundy BN et al (1987) Surgical pathologic spread patterns of endometrial cancer. Cancer 60:2035–2041PubMedCrossRef
10.
Zurück zum Zitat Boronow RC, Morrow CP, Creasman WT, Disaia PJ et al (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825–832PubMed Boronow RC, Morrow CP, Creasman WT, Disaia PJ et al (1984) Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 63:825–832PubMed
11.
Zurück zum Zitat Mo Burrel, Franklin EW, Powell JL (1984) Endometrial cancer:evaluation of spread and follow up in one hundred eighty-nine patients with stage I or II disease. Am J Obstet Gynecol 144:181–185 Mo Burrel, Franklin EW, Powell JL (1984) Endometrial cancer:evaluation of spread and follow up in one hundred eighty-nine patients with stage I or II disease. Am J Obstet Gynecol 144:181–185
12.
Zurück zum Zitat Sakurai N, Tanaka T, Satosh C, Nishiya M et al (1991) Extracorporeal spread and its prognostic impact in stages 1 and 2 FIGO endometrial carcinoma, Asia-Oceania. J Obstet Gynecol 17:193–201 Sakurai N, Tanaka T, Satosh C, Nishiya M et al (1991) Extracorporeal spread and its prognostic impact in stages 1 and 2 FIGO endometrial carcinoma, Asia-Oceania. J Obstet Gynecol 17:193–201
13.
Zurück zum Zitat Homesley HD, Borono RC, Lewis JR (1976) Treatment of adenocarconoma of the endometrium at Memorial-James Ewing Hospitals, 1945–1965. Obstet Gynecol 47:100–105PubMed Homesley HD, Borono RC, Lewis JR (1976) Treatment of adenocarconoma of the endometrium at Memorial-James Ewing Hospitals, 1945–1965. Obstet Gynecol 47:100–105PubMed
14.
Zurück zum Zitat Takeshima N, Hirai Y, Yano K, Tanaka N et al (1998) Ovarian metastasis in endometrial cancer. Gynecol Oncol 70:183–187PubMedCrossRef Takeshima N, Hirai Y, Yano K, Tanaka N et al (1998) Ovarian metastasis in endometrial cancer. Gynecol Oncol 70:183–187PubMedCrossRef
15.
Zurück zum Zitat Roustowski J, Kupsc W (1982) Factors influencing the results of radiotherapy in cases with inoperable endometrial cancer. Gynecol Oncol 14:185–193CrossRef Roustowski J, Kupsc W (1982) Factors influencing the results of radiotherapy in cases with inoperable endometrial cancer. Gynecol Oncol 14:185–193CrossRef
16.
Zurück zum Zitat Abayomi O, Tak W, Emami B, Anderson B et al (1982) Treatment of endometrial carcinoma with radiotherapy alone. Cancer 49:2466–2469PubMedCrossRef Abayomi O, Tak W, Emami B, Anderson B et al (1982) Treatment of endometrial carcinoma with radiotherapy alone. Cancer 49:2466–2469PubMedCrossRef
17.
Zurück zum Zitat Taghian A, Pernot M, Hoffstetter S, Luporsi E et al (1988) Radiation therapy alone for medically inoperable patients with adenocarcinoma of endometrium. Int J Radiat Oncol Biol Phys 15:1135–1140PubMedCrossRef Taghian A, Pernot M, Hoffstetter S, Luporsi E et al (1988) Radiation therapy alone for medically inoperable patients with adenocarcinoma of endometrium. Int J Radiat Oncol Biol Phys 15:1135–1140PubMedCrossRef
18.
Zurück zum Zitat Chan JK, Lin YG, Monk BJ et al (2001) Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet Gynecol 97:707–711PubMedCrossRef Chan JK, Lin YG, Monk BJ et al (2001) Vaginal hysterectomy as primary treatment of endometrial cancer in medically compromised women. Obstet Gynecol 97:707–711PubMedCrossRef
19.
Zurück zum Zitat Berretta R, Merisio C, Melpignano M, Rolla M et al (2008) Vaginal versus abdominal hysterectomy in endometrial cancer: a retrospective study in a selective population. Int J Gynecol Cancer 18:797–802PubMedCrossRef Berretta R, Merisio C, Melpignano M, Rolla M et al (2008) Vaginal versus abdominal hysterectomy in endometrial cancer: a retrospective study in a selective population. Int J Gynecol Cancer 18:797–802PubMedCrossRef
20.
Zurück zum Zitat Susini T, Massi G, Ammuni G et al (2005) Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly. Gynecol Oncol 96(2):362–367PubMedCrossRef Susini T, Massi G, Ammuni G et al (2005) Vaginal hysterectomy and abdominal hysterectomy for treatment of endometrial cancer in the elderly. Gynecol Oncol 96(2):362–367PubMedCrossRef
21.
Zurück zum Zitat Chan JK et al (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer. Cancer 107(8):1823–1830PubMedCrossRef Chan JK et al (2006) Therapeutic role of lymph node resection in endometrioid corpus cancer. Cancer 107(8):1823–1830PubMedCrossRef
22.
Zurück zum Zitat Abu Freij M, Nieto JJ et al (2009) The role of omental biopsy in endometrial cancer staging. Gynecol Surg 6:251–253CrossRef Abu Freij M, Nieto JJ et al (2009) The role of omental biopsy in endometrial cancer staging. Gynecol Surg 6:251–253CrossRef
Metadaten
Titel
The use of MRI for selecting patients with endometrial cancer and significant co-morbidities for vaginal hysterectomy
Publikationsdatum
01.05.2011
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1541-y

Weitere Artikel der Ausgabe 5/2011

Archives of Gynecology and Obstetrics 5/2011 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.